NutribandNTRB -0.93%59 Market Cap is $38.66 Mil as of Jun. 30, 2026. GuruFocus rates NTRB with a GF Score™ of 59/100 and a GF Value™ of $3.25 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,428 Biotechnology companies, Nutriband ranks worse than 67.16% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nutriband's share price for the quarter that ended in Apr. 2026 was $3.865. Nutriband's Shares Outstanding (EOP) for the quarter that ended in Apr. 2026 was 12.16 Mil. Therefore, Nutriband's market cap for the quarter that ended in Apr. 2026 was $46.98 Mil.
Nutriband's quarterly market cap
declined
from Oct. 2025 ($81.81 Mil) to Jan. 2026 ($58.23 Mil) and
declined
from Jan. 2026 ($58.23 Mil) to Apr. 2026 ($46.98 Mil).
Nutriband's annual market cap
increased
from Jan. 2024 ($23.12 Mil) to Jan. 2025 ($91.81 Mil) but then
declined
from Jan. 2025 ($91.81 Mil) to Jan. 2026 ($58.23 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nutriband's Enterprise Value for Today is $34.89 Mil.
Nutriband (NAS:NTRB) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nutriband Market Cap Related Terms
Nutriband Market Cap Historical Data
* Premium members only.
The historical data trend for Nutriband's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Nutriband's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutriband Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nutriband's Market Cap distribution charts can be found below:
* The bar in red indicates where Nutriband's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nutriband's Market Cap for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nutriband (NTRB) has a Market Cap of $38.66 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nutriband and its competitors. According to the industry distribution chart, Nutriband ranks #959 out of 1428 companies in the Biotechnology industry, placing it in the top 67.2%.
Is Nutriband's Market Cap too high?
Nutriband's current Market Cap is $38.66 Mil. The Biotechnology industry median Market Cap is 119.44. Nutriband's value of $38.66 Mil is 67.6% below this industry median. Based on the distribution chart, Nutriband ranks #959 out of 1428 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Nutriband has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nutriband's Market Cap compare to INMB and GRCE?
According to the Biotechnology industry distribution chart, Nutriband ranks #959 out of 1428 companies for Market Cap. This places Nutriband in the lower half of its industry. The industry median Market Cap is 119.44. Nutriband's value of $38.66 Mil is 67.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.44, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nutriband's current Market Cap of $38.66 Mil is 67.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nutriband and its competitors. For the Biotechnology industry, the median Market Cap is 119.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutriband's current Market Cap is $38.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutriband stock overvalued right now?
Based on GuruFocus' analysis, Nutriband (NTRB) is currently considered Fairly Valued. The stock's GF Value™ is $3.25, compared to a current price of $3.18 — trading 2.2% below its estimated fair value. The current Market Cap is $38.66 Mil and 67.6% below the Biotechnology industry median of 119.44. Nutriband's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nutriband (NTRB), the current Market Cap is $38.66 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nutriband (NTRB) Overvalued in 2026?
Based on GuruFocus' analysis, Nutriband stock appears to be undervalued.
The current stock price of $3.18 is trading 2.2% below its estimated GF Value™ of $3.25.
GuruFocus considers Nutriband to be Fairly Valued.
Key valuation signals for NTRB:
Market Cap: $38.66 Mil
GF Value™: $3.25 vs. price of $3.18 (2.2% below fair value)
Industry Position: 67.6% below the Biotechnology median (#959 of 1428)
No single metric tells the full story. See the NTRB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
59GF Score
Get the complete analysis for NTRB
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NTRB has been successfully added to your 
